Skip to search formSkip to main contentSkip to account menu

vanadyl sulfate

Known as: VOSO4, oxosulfatovanadium(IV) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
Vanadyl sulfate (VOSO(4)) is an oxidative form of vanadium that in vitro and in animal models of diabetes has been shown to… 
Highly Cited
1997
Highly Cited
1997
Exposure to air pollution particles can be associated with increased human morbidity and mortality. The mechanism(s) of lung… 
Highly Cited
1996
Highly Cited
1996
We compared the effects of oral vanadyl sulfate (100 mg/day) in moderately obese NIDDM and nondiabetic subjects. Three-hour… 
Highly Cited
1995
Highly Cited
1995
We examined the in vivo metabolic effects of vanadyl sulfate (VS) in non-insulin-dependent diabetes mellitus (NIDDM). Six NIDDM… 
Highly Cited
1995
Highly Cited
1995
When rats with streptozotocin (STZ)-induced diabetes were given a daily intraperitoneal (i.p.) injection of VOSO4 (+4 oxidation… 
Highly Cited
1989
Highly Cited
1989
Recent reports have suggested that vanadium in the form of vanadyl (+IV) possesses insulin-like activity. Therefore, in the… 
Highly Cited
1984
Highly Cited
1984
Highly Cited
1979
Highly Cited
1979